{"id":"0cd6f22e-db05-45ee-bd60-c5683f0e23b9","kind":"news","code":"0cd6f22e-db05-45ee-bd60-c5683f0e23b9","name":"Anda Biotechnology completes equity financing for an undisclosed amount","nameBasis":"translated-title","summary":"On 2026-04-10, according to Xiniu Data, Anda Biotechnology completed equity financing for an undisclosed amount. The investor was Gongqingcheng Kunyuan Investment Partnership (Limited Partnership). The company develops personalized tumor neoantigen vaccines.","description":"","country":null,"category":null,"originalName":"安达生物完成股权投资融资，金额未披露","eventDate":"2026-04-10T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:20.221Z","englishUpdatedAt":"2026-10-20T18:21:37.067Z","reviewedAt":"2026-10-20T18:21:37.067Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"e92a25ca2ba4cace28de0aecc90f26f6f1f3fc6c3422546a2ce55bcd3e48cadb","companyId":"64d65934-0d53-4cdb-badb-47b03b82f51b","foundedYear":null,"logoUrl":null,"originalText":"2026年4月10日，据烯牛数据报道，安达生物完成股权投资融资，金额未披露。投资方为共青城坤元投资合伙企业（有限合伙）。该公司为个性化肿瘤新抗原疫苗研发商。","sources":[],"related":[{"id":"64d65934-0d53-4cdb-badb-47b03b82f51b","kind":"companies","code":"UB-C6779","name":"Anda Biotechnology","nameBasis":"transliterated","summary":"Personalized tumor neoantigen therapies and AI-assisted drug development","description":"","country":"China","category":null,"originalName":"安达生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:24:40.931Z","reviewedAt":"2026-10-20T18:24:40.931Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"9a37202fe58194d6131c5821b131d883fee0543deff2a7f69d004e35addb980b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C6779"},{"id":"861445f5-39c3-4e41-83aa-7e8f98b0ba5a","kind":"institutions","code":"UB-I10534","name":"Gongqingchengkunyuan Investment Partnership","nameBasis":"transliterated","summary":"","description":"","country":null,"category":null,"originalName":"共青城坤元投资合伙企业","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:16:41.528Z","englishUpdatedAt":"2026-10-15T18:35:35.138Z","reviewedAt":"2026-10-15T18:35:35.138Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"aa4fd46c3f9e17b97f74569559adb8e18ff97dae8d750553ca914883efc7b080","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gongqingchengkunyuan-investment-partnership"},{"id":"a3b86de9-06ce-47f9-a37d-a13cc579f6a0","kind":"institutions","code":"UB-I9294","name":"Gongqingchengkunyuan Investment Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"","description":"","country":null,"category":null,"originalName":"共青城坤元投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T15:52:22.325Z","englishUpdatedAt":"2026-10-15T17:35:39.520Z","reviewedAt":"2026-10-15T17:35:39.520Z","snapshotAt":"2026-10-15T16:06:35.585Z","sourceHash":"1b60a08407b5d2a59aa56813244a7b804b8d47c6fbbc46d5e517c64a2eb8bb70","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gongqingchengkunyuan-investment-partnership-limited-partnership"}],"path":"/news/0cd6f22e-db05-45ee-bd60-c5683f0e23b9","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Anda Biotechnology","path":"/companies/UB-C6779"}},"canonical":"https://uniquebase.ai/news/0cd6f22e-db05-45ee-bd60-c5683f0e23b9"}